News
NAFDAC Issues Public Alert on Counterfeit Postinor-2 in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public health alert warning Nigerians about the circulation of falsified batches of Postinor-2 (Levonorgestrel 0.75mg), a popular emergency contraceptive pill.
According to NAFDAC, the counterfeit products were detected after the Society for Family Health (SFH), the official marketer, confirmed that they did not import the suspicious batches into Nigeria.
How to Spot the Fake Postinor-2
The agency highlighted noticeable differences between the genuine and counterfeit packs:
- The pin verification sticker on the fake has a smaller font size and wrongly spells “Veify” instead of “Verify.”
- On the back of the counterfeit packs, the word “Distributed in Nigeria” is misspelled as “Distnibuted in Nigeria.”
Product Details
Original Batch (Authentic):
- Batch No: T32458H
- Mfg. Date: 02/2023
- Exp. Date: 02/2027
- NRN: 04-6985
Counterfeit Batch Type 1:
- Batch No: T36184B
- Mfg. Date: 08/2024
- Exp. Date: 08/2028
- NRN: 04-6985
Counterfeit Batch Type 2:
- Batch No: 332
- Mfg. Date: 03/2023
- Exp. Date: 02/2027
- NRN: 04-6985
Health Risks of Counterfeit Postinor-2
NAFDAC warned that falsified versions of Postinor-2 may contain incorrect or harmful ingredients, improper doses of levonorgestrel, or contaminants, which pose serious health risks such as:
- Failure of contraceptive effect (unintended pregnancy)
- Toxic or harmful side effects
- Allergic reactions and organ damage
- Unpredictable long-term reproductive health consequences
- In extreme cases, death
NAFDAC’s Response
The agency has directed all its zonal directors and state coordinators to carry out surveillance and mop-up operations to remove the falsified products from circulation.
Healthcare professionals, distributors, and retailers are urged to exercise caution, ensure medicines are sourced only from authorized suppliers, and carefully inspect packaging before dispensing.
How to Report Suspected Counterfeits
Consumers and health workers are advised to report suspicious medicines or adverse side effects through the following channels:
- Phone: 0800-162-3322
- Email: sf.alert@nafdac.gov.ng | pharmacovigilance@nafdac.gov.ng
- Website: www.nafdac.gov.ng
- Med-Safety App: Available on Android and iOS
The notice will also be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).
Read more
